Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02305134

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:37:21.692914+00:00

Published At

2019-03-19T00:00:00+00:00

Record Updated At

2019-03-19

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Attention Deficit Disorder With Hyperactivity Disease", "Hyperkinesis", "Attention Deficit and Disruptive Behavior Disorders"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2019-03-19"

protocolSection.identificationModule.nctId

"NCT02305134"

protocolSection.identificationModule.officialTitle

"Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE1", "PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Attention Deficit Disorder With Hyperactivity Disease (protocolSection.conditionsModule.conditions)
• Hyperkinesis (protocolSection.conditionsModule.conditions)
• Attention Deficit and Disruptive Behavior Disorders (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.